Class I indications for indefinite ARB therapy:
- stable angina pectoris undergoing myocardial revascularisation + HF + LV EF < 40% + ACEI inhibitors intolerance,
- stable angina pectoris undergoing myocardial revascularisation + LV EF < 40% + prior MI + ACEI inhibitors intolerance.
Class IIa indications for indefinite ARB therapy:
- stable angina pectoris undergoing myocardial revascularisation + LV EF > 40% + ACEI inhibitors intolerance,
- stable angina pectoris undergoing myocardial revascularisation + absence of HF + LV EF < 40% + absence of prior MI + ACEI inhibitors intolerance.
- stable angina pectoris undergoing myocardial revascularisation + absence of HF + LV EF < 40% + absence of prior MI + ACEI inhibitors intolerance.